Skip to content

Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors

Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider

Journal of Vision March 17, 2010 DOI: 10.1167/5.8.683 via OpenAlex

Summary

AI-generated from the abstract

A hallucinogenic drug that activates serotonin receptors, psilocybin, impairs the ability to track multiple moving objects but does not affect spatial working memory, indicating a functional separation between these two cognitive processes. Blocking one type of serotonin receptor (5-HT2A) with ketanserin did not prevent this attentional deficit, pointing to the involvement of another receptor (5-HT1A) instead. The impairment may stem from difficulty ignoring distractions rather than a reduction in attentional capacity itself.

Study at a glance

Characteristics Within-subjects pharmacological challenge Peer reviewed
Sample size 8
Population Healthy human volunteers
Interventions Psilocybin Ketanserin
Topics Psilocybin Serotonin
Keywords Ketanserin Working memory Prefrontal cortex Agonist
Citations 6
Key finding Psilocybin significantly reduced attentional tracking ability but had no significant effect on spatial working memory, and ketanserin pretreatment did not attenuate this attentional deficit.

Abstract

Increasing evidence suggests a link between attention, working memory, serotonin (5-HT) and prefrontal cortex activity. In an attempt to tease out the relationship between these elements, this study tested the effects of the hallucinogenic 5-HT1A/2A receptor agonist psilocybin alone and after pretreatment with the 5-HT2A antagonist ketanserin on multiple object tracking and spatial working memory, in eight healthy human volunteers. Psilocybin significantly reduced attentional tracking ability, but had no significant effect on spatial working memory, suggesting a functional dissociation between the two tasks. In line with the 5-HT1A receptor's known role in modulating prefrontal activity, pretreatment with ketanserin did not attenuate the effect of psilocybin on attentional performance, suggesting a primary involvement of the 5-HT1A receptor in the observed deficit. Based on physiological and pharmacological data, we propose that this impaired attentional performance may reflect reduced ability to suppress or ignore distracting stimuli rather than reduced attentional capacity.

Explore topics

Comments

No comments yet.

Log in to comment